cytokines such as IL-1, IL-6, and TNF-α. 9, 10 In contrast, an M2 KC-dominant response ameliorates IRI in miR-155 deficiency mice. 11 It has been shown that M1 and M2 macrophages regulate type 1 T helper cell (Th1) and type 2 T helper cell (Th2) responses, respectively. 12 Activated KCs promote intra-hepatic Th1 cell infiltration in a necro-inflammation mouse model. 13 On the other hand, KCs derived from accepted liver allograft inhibit AR of rat OLT by inducing T cells apoptosis and promoting Th2 cell differentiation. 14 These findings suggest that the role of KCs is associated with their polarization state and the increase in M2 KCs could ameliorate AR of OLT. FGL2, a member of fibrinogen family, has 2 protein forms, membrane-bound form (mFGL2) with coagulation activity and secreted form (sFGL2) with immunosuppressive properties. 15, 16 FGL2 is involved in regulating progressions of many diseases. [17] [18] [19] [20] [21] [22] [23] [24] FGL2 deletion in Tregs contributes to the development of autoimmune glomerulonephritis in mice.
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FGL2 is upregulated in tolerant cardiac and liver allografts in mice, and over-expression of FGL2 could inhibit rat cardiac allograft rejection. 22, 23 Recent study shows that FGL2
promotes glioma growth by expanding tumor-associate macrophages via FcγRIIB pathway. 24 These suggest that FGL2 is involved in the regulation of macrophages function and transplant tolerance. However, little is known about the effects of sFGL2 on AR of OLT by regulating KCs.
In this study, we found that FGL2 expression and M2 KCs were increased in tolerance group of rat OLT. We also found that sFGL2 could induce KCs M2 polarization and inhibit STAT1 and NF-κB signaling pathway in vitro. Importantly, sFGL2 could inhibit AR of rat OLT via inducing KCs M2 polarization in vivo.
| MATERIAL AND METHODS

| Animals and liver transplantation
Lewis and Brown Norway (BN) rats were obtained from Animal Research Center of Chongqing Medical University (Chongqing, China) and maintained in a specific pathogen free (SPF) environment. The AR (Lewis to BN) and tolerance model (BN to Lewis) of OLT were performed according to the two-cuff method from Kamada. 25 The ischemic time was between 13 and 18 minutes. There were 6-8 recipients weighing 230-280 g in each group.
| Isolation of KCs and cell Culture
KCs were isolated and purified from liver tissue using modified methods 26 ( Figure S1 ). KCs were cultured into sixwell plate at a density of 1 × 10 6 /well in media, containing RPMI 1640 (Hyclone, USA) with 10% Fetal Bovine Serum (Hyclone, USA) and 1% streptomycin and penicillin (Sigma, USA), at 37°C under an atmosphere of 5% CO 2 .
| Treatment of KCs
We used r-FGL2 (Cloud-clone, USA) in vitro experiment. KCs were co-stimulated with or without 1 μg/mL LPS and 20 ng/mL IFN-γ (LPS/IFN-γ) (Sigma, USA) 27 in the presence of r-FGL2 (4 μg/mL) for 24 hours ( Figure S2 ). KCs cultured in normal media were set as control group.
| Flow cytometry analysis
KCs were collected and stained with PE-anti-CD206, FITCanti-F4/80, or specific isotype antibodies (eBioscience, USA). BD FACS Calibur flow cytometer was used, and data were processed with CytExpert software.
| Cytokine assay
KCs culture supernatants were collected 24 hours after treatment and rat serums were collected on day 7 after OLT. The levels of IL-12, TNF-a, IL-10, TGF-β (4A Biotech, China), and sFGL2 (Cloud Clone, USA) were examined according to the manufacturer's instructions of ELISA Kits. 
| Quantitative real-time RT-PCR (qRT-PCR)
Total RNA was extracted using TRIzol reagent (Takara, Japan) and used as a template for reverse transcription into cDNA with Reverse Transcript Reagents kit (Takara, Japan).
The analysis was performed in a Real-Time Detection System (ABI 7500, Thermo Fisher Scientific) following the manufacturer's instructions for the SYBR Prime Script RT-PCR Kit (Bio-RAD, USA). The primers were listed in Table 1 .
| Western blot analysis
Total protein was extracted from KCs or allografts using protein extraction kit (Beyotime, Jiangsu, China). Protein concentrations were detected using a BCA protein quantitative kit (Beyotime, Jiangsu, China). Indicated primary antibodies against Arg-1, STAT1, p-STAT1 (CST, USA), IκBα, p-IκBα, p65, and p-p65 (Santa Cruz Biotechnology, USA) were used in Western blot following the manufacturer's instructions. GAPDH protein was used as control. Signals were detected through the chemiluminescent reaction using a gel imaging system (ChemiScope 2850, Clinx Science, Shanghai, China).
| Construction of AR model of rat OLT with over-expression of sFGL2
Adeno-associated virus expressing FGL2 (AAV-FGL2) and GFP (AAV-null) were purchased from HanBio (Shang Hai, China). Equivalent dose of AAV-FGL2 or AAV-null viral genome (3 × 10 12 vector genomes/kg) were injected parallel to BN rats 1 month prior to OLT (Lewis to BN) via tail vein. The mRNA levels and serum concentration of sFGL2 were detected by qRT-PCR and ELISA, respectively.
| Morphological changes and function of liver grafts
Allografts were fixed in 10% paraformaldehyde solution, embedded in paraffin blocks, sectioned, and stained with hematoxylin and eosin (H&E) according to standard protocol. Banff criteria were used to score the AR. 28 The serum was obtained from recipients on day 7 after OLT and used to detect ALT, AST, and TBIL (Jiancheng Bioengineering Institute, China).
| Adoptive transfer of KCs
KCs ( 
| RESULTS
| sFGL2 is upregulated in rat OLT models of tolerance and positively associated with the frequency of M2 KCs
To investigate the expression profiles of FGL2 in rat liver transplantation, we established rat OLT models of AR and tolerance. qRT-PCR results showed that FGL2 mRNA levels of allografts were higher in tolerance group than that in AR group. ELISA analysis showed a similar expression pattern ( Figure 1A ). KCs were then isolated from the grafts to detect the CD206 expression. Flow cytometry analysis showed that the CD206 expression was increased in tolerance group compared with that in AR group ( Figure 1B,C) . Spearman correlation analysis showed FGL2 expression was positively associated with the frequencies of M2 KCs in rat OLT models of tolerance ( Figure 1D ).
| sFGL2 promotes KCs M2 polarization
sFGL2 has been reported to regulate the polarization of tumor-associated macrophages in glioma. 24 We hypothesized that sFGL2 could positively regulate KCs M2 polarization. To verify it, primary KCs were isolated from Lewis rat and treated with LPS/IFN-γ and r-FGL2. We found that the productions of IL-12 and TNF-α from KCs were increased under LPS/IFN-γ stimulation, while decreased with the combination of r-FGL2 and LPS/IFN-γ. In parallel, the productions of IL-10 and TGF-β were increased with the combination of r-FGL2 and LPS/IFN-γ ( Figure 2A ). Flow cytometry assays showed that the CD206 expression levels were higher in KCs with r-FGL2 and LPS&IFN-γ treatment compared to those in KCs stimulated by LPS&IFN-γ ( Figure 2B ). Together, these data suggested sFGL2 promoted the KCs M2 polarization.
| sFGL2 inhibits STAT1 and NF-κB signaling pathway
It has been reported that STAT1 and NF-κB signaling pathways are involved in the regulation of macrophage polarization. We hypothesized that sFGL2 could induce KCs M2 polarization via STAT1 and NF-κB signaling pathways. As expected, Western blot analysis showed that the levels of phosphorylated STAT1, IκBa and NF-κB p65 were increased in KCs with LPS/IFN-γ treatment compared to KCs without LPS/IFN-γ treatment, while the increased expression levels could be attenuated by r-FGL2 introduction ( Figure 2C,D) . These results showed that sFGL2 inhibited the STAT1 and NF-κB pathways in KCs. 
| sFGL2 inhibits AR of rat OLT
To explore the effect of sFGL2 on AR of rat OLT, we established rat OLT model with recipient receiving AAV-FGL2 treatment ( Figure 3A,B) . H&E staining examination for allografts showed less triads (lymphocytes, neutrophils, and eosinophils) infiltration in the portal tracts, minor venous endothelial inflammation and milder bile duct damage in recipients receiving AAV-FGL2 treatment compared to those in recipients receiving AAV-null treatment ( Figure 3C ). We then scored the H&E staining result according to Banff schema. We found that the rejection activity index (RAI) scores of allografts in recipients receiving AAV-FGL2 treatment were lower than that of allografts in recipients receiving AAV-null treatment ( Figure 3D ). Consistently, the overall survival of recipients receiving AAV-FGL2 treatment was longer than that of recipients receiving AAV-null treatment ( Figure 3E ). We also found that the serum levels of ALT, 
F I G U R E 3 sFGL2 over-expression in recipients alleviates AR of rat OLT (Lewis to BN). A,B,
The mRNA and serum levels of sFGL2 in liver tissues from BN rats (control group), AAV-FGL2-treated BN rats or AAV-null-treated BN rats were examined using qRT-PCR or ELISA, respectively. C, H&E staining of allografts on day 7 after OLT. (D) RAI scores were performed to grade AR according to Banff schema. E, KaplanMeier curve was used to perform the survival of recipients. F, Serum levels of ALT, AST, and TBIL on day 7 after OLT. G, The mRNA levels of IL-12, TNF-α, IL-10, TGF-β and Arg-1 in KCs isolated from allografts on day 7 after OLT were detected using qRT-PCR. H, The protein level of Arg-1 in allografts was measured using Western blot. ***P < .001 compared to control group or AR group. (Ctrl: control group, AAV-FGL2: AAV-FGL2-treated BN rats, AAV-null: AAV-null-treated BN rats, AR: saline-treated BN recipients, AR-AAV-FGL2: AAV-FGL2-treated BN recipients, AR-AAV-null: AAV-null-treated BN recipients)
F I G U R E 4 Adoptive transfer of KCs isolated from allografts of AAV-FGL2-treated BN recipients ameliorates AR of rat OLT (Lewis to BN).
A, H&E staining of allografts on day 7 after OLT. B, RAI scores were performed to grade AR according to Banff schema. C, Kaplan-Meier curve was used to perform the survival of recipients. D, Serum levels of ALT, AST, and TBIL on day 7 after OLT. ***P < .001 compared to AR group. AST, and TBIL were decreased in recipients receiving AAV-FGL2 treatment compared with those in recipients receiving AAV-null treatment ( Figure 3F ). Moreover, we found that the mRNA levels of IL-10, TGF-β, and Arg-1 in KCs from the allografts of recipients receiving AAV-FGL2 treatment were higher compared with those in KCs from the allografts of recipients receiving AAV-null treatment ( Figure 3G ). Western blot showed a similar expression pattern of Arg-1 ( Figure 3H ). These results showed that sFGL2 could inhibit the AR of rat OLT and induce KCs M2 polarization in vivo.
| sFGL2 ameliorates AR via inducing
KCs M2 polarization
Our previous study showed that sFGL2 could inhibit AR of rat OLT and induce KCs M2 polarization both in vitro and in vivo. We speculated that the KCs M2 polarization was involved in the AR inhibition of rat OLT induced by sFGL2. To examine it, the KCs isolated from the liver tissue of Lewis rat, allograft of recipient receiving AAV-FGL2 or AAV-null treatment, were adoptively transferred to OLT rats. H&E staining examinations showed less triads infiltration, minor venous endothelial inflammation, and milder bile duct damage in allografts of recipients receiving AAV-FGL2-KCs transfer compared with those in allografts of recipients receiving AAV-null-KCs or Lew-KCs transfer ( Figure 4A ). The RAI scores of allografts in recipients receiving AAV-FGL2-KCs transfer were lower than those of allografts in recipients receiving AAV-null-KCs or Lew-KCs transfer ( Figure 4B ), and the overall survival of recipients receiving AAV-FGL2-KCs transfer was longer than that of recipients receiving AAV-null-KCs or Lew-KCs transfer ( Figure 4C) . Consistently, the liver function of recipients receiving AAV-FGL2-KCs transfer was improved ( Figure 4D ). These results showed that sFGL2 ameliorated AR by inducing KCs M2 polarization.
| DISCUSSION
In this study, we clarify that sFGL2 induces KCs M2 polarization, and inhibits STAT1 and NF-κb signaling pathway in KCs. Importantly, we provide the first evidence that sFGL2 ameliorates AR of rat OLT, at least in part, via inducing KCs M2 polarization.
Several studies show that the expressions of FGL2 are upregulated in mouse-tolerant hepatic and cardiac allografts, and over-expression of sFGL2 contributes to the acceptance of a fully mismatched heart allograft in mice. 23, 29 Interestingly, other studies show that the serum levels of sFGL2 are higher in patients with AR after renal transplantation compared to patients without AR. 19, 30 These discrepancies might be due to spatiotemporal expression and dynamic changes of sFGL2 in transplantation. Our study showed that both mRNA and serum levels of FGL2 were higher in tolerance group of rat OLT than those in AR group. Importantly, we found that the expression of FGL2 was positively associated with the frequency of M2 KCs, suggesting that sFGL2 may play a suppressive role in AR of rat OLT by regulating KCs M2 polarization. KCs regulate the immune homeostasis after liver transplantation and KCs M2 polarization contributes to the extension of liver allograft survival. 11, 31 A recent study shows that sFGL2 increases the frequency of glioma-associated M2 macrophages in mice. 24 Although extensive studies have demonstrated that sFGL2 acts on macrophages through the 2 special receptors, FcγRIIb and FcγRIII, the downstream signaling pathway responsible for the polarization of KCs is unclear. 35, 36 FcγRIIb is decreased by the TLR4 agonists, in contrast, upregulated by IL-4 and IL-10. [37] [38] [39] Moreover, the suppression of immune globulin on macrophages via inhibiting STAT1 signaling pathway is FcγRIII dependent. 40 It has been shown that Tim-3 induces M2 macrophage polarization via inhibiting STAT1-miR-155-SOCS1 pathway. 41 Based on these findings, we speculated that sFGL2 induced KCs M2 polarization by inhibiting STAT1 and NF-κB pathway.
As expected, we found that r-FGL2 significantly inhibited the phosphorylation of STAT1 and NF-κB induced by LPS/IFN-γ. However, the exact function of Fcγ receptors on KCs and detailed signaling pathway needs to be further investigated.
Taken together, we revealed that sFGL2 induced KCs M2 polarization both in vitro and in vivo. We found sFGL2 could suppress the STAT1 and NF-κB signaling pathway, which might contribute to KCs M2 polarization. Importantly, we | PAN et Al.
revealed that both over-expression of sFGL2 in recipients and adoptive transfer of KCs from sFGL2 over-expression allografts contributed to alleviating AR of rat OLT. Our results might provide a new preventive and therapeutic strategy to manage patients with AR after liver transplantation.
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